Publication | Closed Access

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

Metastatic Breast CancerWaist-to-hip RatioBreast OncologyMedicinePharmacologyPathologyAromataseBreast CancerCancer TreatmentAromatase InhibitorsOncologyEndocrine-related Cancer